Immunological activity of larch arabinogalactan and Echinacea: A preliminary, randomized, double-blind, placebo-controlled trial

Alternative Medicine Review

Volumn 7, Issue 2, 2002, Pages 138-149

  Kim, Linda S ^a   Waters, Robert F ^a   Burkholder, Peter M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOGALACTAN; ECHINACEA EXTRACT; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLACEBO; PROPERDIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYTIC METHOD; ANXIETY; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEART PALPITATION; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOREACTIVITY; NERVOUSNESS; PHASE 1 CLINICAL TRIAL; PLANT ROOT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SPECIES DIFFERENTIATION;

ADULT; DEFECATION; DOUBLE-BLIND METHOD; ECHINACEA; FEMALE; GALACTANS; HUMANS; LACTOBACILLUS ACIDOPHILUS; MIDDLE AGED; PLANT EXTRACTS; PROPERDIN; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 0036234496     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Echinacea species as potential immunostimulatory drugs
2. The American coneflower: A prophylactic role involving nonspecific immunity
3. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea
4. Immunologic studies of plant combination preparations. In-vitro and in-vivo studies on the stimulation of phagocytosis
5. Immunologic in vivo and in vitro studies on Echinacea extracts
6. Effect of a plant immunostimulant on phagocytosis of erythrocytes by the reticulohistiocytary system of isolated perfused rat liver
7. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis
8. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes
9. Immunomodulating activity of ethanol-water extracts of the roots of Echinacea gloriosa L., Echinacea angustifolia DC, and Rudbeckia speciosa Wenderoth tested on the immune system in C57BL6 inbred mice
10. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans
11. Testing for immunomodulating effects of ethanol-water extracts of the aboveground parts of the plants Echinacea (Moench) and Rudbeckia L
12. The effects of plant preparations on cellular functions in body defense
13. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system
14. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea
15. Immunomodulation with Viscum album and Echinacea purpurea extracts
16. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea
17. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo-controlled, double-blind clinical trial
18. Echinacea purpurea radix for strengthening the immune response in flu-like infections
19. The influence of immune-stimulating effects of pressed juice from Echinacea purpurea on the course and severity of colds. Results of double-blind study
20. Clinical application of extracts of Echinacea purpurea or Echinacea pallida. Critical evaluation of controlled clinical studies
21. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections
22. Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (echinacin) in patients with far advanced colorectal cancers: Preliminary results
23. In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species
24. Anti-inflammatory activity of Echinacea angustifolia fractions separated on the basis of molecular weight
25. Evidence from two classic irritation tests for an anti-inflammatory action of a natural extract, Echinacina B
26. Anti-inflammatory activity of a polysaccharidic fraction of Echinacea angustifolia
27. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions
28. Toxicity of Echinacea purpurea. Acute, subacute and genotoxicity studies
29. The effect of Echinacea purpurea Moench on phagocytosis in granulocytes measured by chemiluminescence
30. The effects of Echinacea angustifolia on non-specific cellular immunity in the mouse
31. Echinacea drugs-effects and active ingredients
32. Immunostimulating action of polysaccharides (heteroglycans) from higher plants
33. Echinacea: When should it be used?
34. Echinacea: Anatomy, phytochemical pattern, and germination of the achene
35. Studies on antigen specificity of immunoreactive arabinogalactan proteins extracted from Baptisia tinctoria and Echinacea purpurea
36. Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis
37. Relationship between structure and activity of an anti-complementary arabinogalactan from the roots of Angelica acutiloba Kitagawa
38. The major peptic arabinogalactan having activity on the reticuloendothelial system from the roots of rhizomes of Saposhnikovia divaricata
39. Effects of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro: Enhancement of the activity by a polysaccharide preparation, Krestin
40. Arabinogalactan core structure and immunological activities of ukonan C, an acidic polysaccharide from the rhizome of Curcuma longa
41. Larch arabinogalactan: Clinical relevance of a novel immune-enhancing polysaccharide
42. Larch arabinogalactan. Research report
43. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
44. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups
45. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
46. Degradation of complex carbohydrates by Bifidobacterium spp
47. Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects
48. Digestion of larch arabinogalactan by a strain of human colonic Bacteroides growing in continuous culture